Thermo Fisher Scientific's strong first-quarter results surpassed analysts' expectations, with adjusted EPS at $5.15 and revenue at $10.36 billion. Despite lowering full-year adjusted EPS forecast to $22.30 due to policy changes, shares rose 5%.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing